160 related articles for article (PubMed ID: 17762170)
1. Sphingolipid metabolite ceramide causes metabolic perturbation contributing to HERG K+ channel dysfunction.
Bai Y; Wang J; Shan H; Lu Y; Zhang Y; Luo X; Yang B; Wang Z
Cell Physiol Biochem; 2007; 20(5):429-40. PubMed ID: 17762170
[TBL] [Abstract][Full Text] [Related]
2. Modulation of HERG K+ channels by chronic exposure to activators and inhibitors of PKA and PKC: actions independent of PKA and PKC phosphorylation.
Shu L; Zhang W; Su G; Zhang J; Liu C; Xu J
Cell Physiol Biochem; 2013; 32(6):1830-44. PubMed ID: 24356123
[TBL] [Abstract][Full Text] [Related]
3. Ceramide modulates HERG potassium channel gating by translocation into lipid rafts.
Ganapathi SB; Fox TE; Kester M; Elmslie KS
Am J Physiol Cell Physiol; 2010 Jul; 299(1):C74-86. PubMed ID: 20375276
[TBL] [Abstract][Full Text] [Related]
4. HIV Tat protein inhibits hERG K+ channels: a potential mechanism of HIV infection induced LQTs.
Bai YL; Liu HB; Sun B; Zhang Y; Li Q; Hu CW; Zhu JX; Gong DM; Teng X; Zhang Q; Yang BF; Dong DL
J Mol Cell Cardiol; 2011 Nov; 51(5):876-80. PubMed ID: 21820442
[TBL] [Abstract][Full Text] [Related]
5. Impairment of HERG K(+) channel function by tumor necrosis factor-alpha: role of reactive oxygen species as a mediator.
Wang J; Wang H; Zhang Y; Gao H; Nattel S; Wang Z
J Biol Chem; 2004 Apr; 279(14):13289-92. PubMed ID: 14973143
[TBL] [Abstract][Full Text] [Related]
6. HERG K+ channel blockade by the novel antiviral drug sophocarpine.
Zhao XL; Qi ZP; Fang C; Chen MH; Lv YJ; Li BX; Yang BF
Biol Pharm Bull; 2008 Apr; 31(4):627-32. PubMed ID: 18379053
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the HERG channel by droperidol depends on channel gating and involves the S6 residue F656.
Luo T; Luo A; Liu M; Liu X
Anesth Analg; 2008 Apr; 106(4):1161-70, table of contents. PubMed ID: 18349188
[TBL] [Abstract][Full Text] [Related]
8. Effects of phosphodiesterase (PDE) inhibitors on human ether-a-go-go related gene (hERG) channel activity.
Yunomae K; Ichisaki S; Matsuo J; Nagayama S; Fukuzaki K; Nagata R; Kito G
J Appl Toxicol; 2007; 27(1):78-85. PubMed ID: 17146843
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of the HERG (KCNH2) K(+) channel by ceramide: evidence for ubiquitin-mediated lysosomal degradation.
Chapman H; Ramström C; Korhonen L; Laine M; Wann KT; Lindholm D; Pasternack M; Törnquist K
J Cell Sci; 2005 Nov; 118(Pt 22):5325-34. PubMed ID: 16263765
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine.
Rajamani S; Eckhardt LL; Valdivia CR; Klemens CA; Gillman BM; Anderson CL; Holzem KM; Delisle BP; Anson BD; Makielski JC; January CT
Br J Pharmacol; 2006 Nov; 149(5):481-9. PubMed ID: 16967046
[TBL] [Abstract][Full Text] [Related]
11. Propofol inhibits hERG K
Han SN; Jing Y; Yang LL; Zhang Z; Zhang LR
Eur J Pharmacol; 2016 Nov; 791():168-178. PubMed ID: 27575519
[TBL] [Abstract][Full Text] [Related]
12. Extracellular K+ is a prerequisite for the function and plasma membrane stability of HERG channels.
Massaeli H; Guo J; Xu J; Zhang S
Circ Res; 2010 Apr; 106(6):1072-82. PubMed ID: 20133899
[TBL] [Abstract][Full Text] [Related]
13. Multiple mechanisms of hERG liability: K+ current inhibition, disruption of protein trafficking, and apoptosis induced by amoxapine.
Obers S; Staudacher I; Ficker E; Dennis A; Koschny R; Erdal H; Bloehs R; Kisselbach J; Karle CA; Schweizer PA; Katus HA; Thomas D
Naunyn Schmiedebergs Arch Pharmacol; 2010 May; 381(5):385-400. PubMed ID: 20229012
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
[TBL] [Abstract][Full Text] [Related]
15. Potential mechanisms for the enhancement of HERG K+ channel function by phospholipid metabolites.
Wang J; Zhang Y; Wang H; Han H; Nattel S; Yang B; Wang Z
Br J Pharmacol; 2004 Feb; 141(4):586-99. PubMed ID: 14744814
[TBL] [Abstract][Full Text] [Related]
16. Thioridazine Induces Cardiotoxicity via Reactive Oxygen Species-Mediated hERG Channel Deficiency and L-Type Calcium Channel Activation.
Liu Y; Xu X; Zhang Y; Li M; Guo J; Yan C; Wang F; Li Y; Ding Y; Li B; Fan P
Oxid Med Cell Longev; 2020; 2020():3690123. PubMed ID: 32064022
[TBL] [Abstract][Full Text] [Related]
17. Effect of sibutramine HCl on cardiac hERG K+ channel.
Kim KS; Kim EJ; Lee HA; Park SJ
Mol Cell Biochem; 2009 Jan; 320(1-2):125-31. PubMed ID: 18781376
[TBL] [Abstract][Full Text] [Related]
18. A novel missense mutation causing a G487R substitution in the S2-S3 loop of human ether-à-go-go-related gene channel.
Kinoshita K; Yamaguchi Y; Nishide K; Kimoto K; Nonobe Y; Fujita A; Asano K; Tabata T; Mori H; Inoue H; Hata Y; Fukurotani K; Nishida N
J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1246-53. PubMed ID: 22764740
[TBL] [Abstract][Full Text] [Related]
19. Molecular determinants of cocaine block of human ether-á-go-go-related gene potassium channels.
Guo J; Gang H; Zhang S
J Pharmacol Exp Ther; 2006 May; 317(2):865-74. PubMed ID: 16397089
[TBL] [Abstract][Full Text] [Related]
20. Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel.
Ridley JM; Milnes JT; Hancox JC; Witchel HJ
J Mol Cell Cardiol; 2006 Jan; 40(1):107-18. PubMed ID: 16288909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
